mepazine has been researched along with Pancreatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Betzel, C; Bockhorn, M; Buchholz, A; El Gammal, AT; Graß, JK; Grupp, K; Güngör, C; Hofmann, BT; Izbicki, JR; Kapis, S; Klemp, C; Konczalla, L; Landschulze, D; Lüddeke, J; Meier, C; Nuguid, T; Perez, DR; Püschel, K; Sauter, G; Schumacher, U; Spriestersbach, SL; Steinberg, P; Uzunoglu, FG; Wenzel, N; Wolski, A; Wolters-Eisfeld, G; Yao, D | 1 |
1 other study(ies) available for mepazine and Pancreatic Neoplasms
Article | Year |
---|---|
Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer.
Topics: Animals; Biperiden; Carcinoma, Pancreatic Ductal; Cell Growth Processes; Cell Line, Tumor; Humans; Mice; Mice, Knockout; Models, Molecular; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; NF-kappa B; Pancreatic Neoplasms; Phenothiazines; Proto-Oncogene Proteins c-rel; Random Allocation; Xenograft Model Antitumor Assays | 2020 |